News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,313 Results
Type
Article (42566)
Company Profile (295)
Press Release (674452)
Multimedia
Podcasts (77)
Webinars (12)
Section
Business (210444)
Career Advice (2096)
Deals (36631)
Drug Delivery (107)
Drug Development (83057)
Employer Resources (175)
FDA (16566)
Job Trends (15413)
News (356074)
Policy (33938)
Tag
2024 BioCapital Digital (13)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2600)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (51416)
ALS (90)
Alzheimer's disease (1387)
Antibody-drug conjugate (ADC) (120)
Approvals (16566)
Artificial intelligence (257)
Autoimmune disease (22)
Automation (15)
Bankruptcy (371)
Best Places to Work (11779)
BIOSECURE Act (19)
Biosimilars (110)
Biotechnology (189)
Bladder cancer (60)
Brain cancer (28)
Breast cancer (265)
Cancer (2121)
Cardiovascular disease (176)
Career advice (1754)
Career pathing (30)
CAR-T (145)
Cell therapy (410)
Cervical cancer (19)
Clinical research (67397)
Collaboration (815)
Compensation (514)
Complete response letters (25)
COVID-19 (2655)
CRISPR (43)
C-suite (230)
Cystic fibrosis (103)
Data (2065)
Decentralized trials (2)
Denatured (27)
Depression (42)
Diabetes (260)
Diagnostics (6434)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (108)
Drug shortages (28)
Duchenne muscular dystrophy (92)
Earnings (88036)
Editorial (37)
Employer branding (21)
Employer resources (149)
Events (114782)
Executive appointments (708)
FDA (17770)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (729)
Gene editing (107)
Generative AI (21)
Gene therapy (302)
GLP-1 (739)
Government (4532)
Grass and pollen (4)
Guidances (51)
Healthcare (19001)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (119)
Indications (27)
Infectious disease (2796)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (93)
Interviews (323)
IPO (16774)
IRA (47)
Job creations (4056)
Job search strategy (1496)
Kidney cancer (9)
Labor market (36)
Layoffs (483)
Leadership (17)
Legal (8390)
Liver cancer (73)
Lung cancer (304)
Lymphoma (141)
Machine learning (5)
Management (59)
Manufacturing (296)
MASH (64)
Medical device (13433)
Medtech (13438)
Mergers & acquisitions (20368)
Metabolic disorders (679)
Multiple sclerosis (75)
NASH (17)
Neurodegenerative disease (88)
Neuropsychiatric disorders (26)
Neuroscience (1913)
NextGen: Class of 2025 (6643)
Non-profit (4524)
Northern California (2544)
Now hiring (38)
Obesity (368)
Opinion (228)
Ovarian cancer (74)
Pain (90)
Pancreatic cancer (81)
Parkinson's disease (147)
Partnered (21)
Patents (228)
Patient recruitment (100)
Peanut (49)
People (59198)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20901)
Phase II (29650)
Phase III (22231)
Pipeline (1127)
Policy (145)
Postmarket research (2656)
Preclinical (8861)
Press Release (68)
Prostate cancer (99)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (389)
Real estate (6261)
Recruiting (67)
Regulatory (23075)
Reports (46)
Research institute (2370)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (73)
Series A (127)
Series B (82)
Service/supplier (12)
Sickle cell disease (55)
Southern California (2191)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3722)
State (2)
Stomach cancer (14)
Supply chain (66)
Tariffs (27)
The Weekly (48)
United States (22241)
Vaccines (690)
Venture capitalists (38)
Weight loss (248)
Women's health (34)
Worklife (15)
Date
Today (29)
Last 7 days (474)
Last 30 days (2401)
Last 365 days (33370)
2025 (9368)
2024 (35773)
2023 (40631)
2022 (51803)
2021 (56334)
2020 (54801)
2019 (47428)
2018 (35787)
2017 (33147)
2016 (32680)
2015 (38629)
2014 (32523)
2013 (27646)
2012 (29747)
2011 (30500)
2010 (28513)
Location
Africa (785)
Alabama (52)
Alaska (7)
Arizona (236)
Arkansas (14)
Asia (40672)
Australia (6520)
California (5814)
Canada (1951)
China (503)
Colorado (256)
Connecticut (263)
Delaware (137)
Europe (86764)
Florida (864)
Georgia (202)
Idaho (57)
Illinois (527)
India (26)
Indiana (309)
Iowa (9)
Japan (153)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (866)
Massachusetts (4395)
Michigan (217)
Minnesota (380)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1676)
New Mexico (29)
New York (1660)
North Carolina (956)
North Dakota (7)
Northern California (2544)
Ohio (194)
Oklahoma (14)
Oregon (38)
Pennsylvania (1315)
Puerto Rico (11)
Rhode Island (30)
South America (1163)
South Carolina (20)
South Dakota (1)
Southern California (2191)
Tennessee (99)
Texas (870)
Utah (173)
Virginia (143)
Washington D.C. (59)
Washington State (539)
West Virginia (3)
Wisconsin (53)
717,313 Results for "remedy pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
International Stroke Conference 2025: Remedy Pharmaceuticals Unveils Landmark CIRARA® Data Demonstrating Significant Improvements in Stroke Outcomes
February 19, 2025
·
4 min read
Press Releases
Remedy Pharmaceuticals to Showcase Groundbreaking Phase 3 CHARM Study Data on CIRARA® at International Stroke Conference 2025
January 29, 2025
·
4 min read
Press Releases
Remedy Pharmaceuticals Receives FDA Guidance to Advance CIRARA for Treatment of Severe Stroke
November 19, 2024
·
1 min read
Press Releases
BioTek reMEDys Names Neal Fitzpatrick Chief Strategy Officer
January 23, 2025
·
2 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
News
Remedy Pharmaceuticals Announces FDA Orphan Drug Designation Granted for the Treatment of Large Territory Acute Ischemic Stroke with CIRARA
October 22, 2024
·
2 min read
Drug Development
Remedy Pharmaceuticals Gets Rights To Acute Stroke Drug Back From Biogen; Announces Clinically Meaningful and Statistically Significant Results From Pre-specified Subgroup and Post Hoc Analyses of Phase 3 Study
Remedy Pharmaceuticals announced that prespecified subgroup analyses from the Phase 3 CHARM clinical trial of CIRARA (IV glibenclamide) showed meaningful improvements in functional outcomes on the modified Rankin Scale (mRS), which were further validated in post hoc analyses.
May 29, 2024
·
4 min read
Drug Development
Remedy Pharmaceuticals’ Phase 3 Trial in Large Lesion Stroke Patients Demonstrates Statistically Significant Effect at One Year
October 1, 2024
·
3 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing
Pluri Inc. announced that its CDMO division has signed a manufacturing agreement with Remedy Cell Ltd, an innovative, biopharmaceutical company developing stem cell-derived, cell-free therapeutics for complex fibrotic conditions.
March 14, 2024
·
5 min read
1 of 71,732
Next
